Why I Was So Tired on a GLP-1 (And What Moved the Needle)

Asleep at 8:40 with the lights on

My daughter woke me up to ask whether she was allowed to go to bed. I had been out cold on the sofa since roughly the end of dinner, upright, still holding a mug.

That was week six, and it was the side effect I was least prepared for. I had braced for nausea. Everybody braces for nausea. Nobody had said a word about the tiredness, and for a while I genuinely wondered whether something else was wrong with me.

It is on the label, with a number

This was the first thing that helped, and it took me two minutes to find.

In the Wegovy trials in adults with obesity or overweight, fatigue was reported by 11% of people on semaglutide 2.4 mg versus 5% on placebo — and the label's own footnote says that category covers fatigue and asthenia, which is the clinical word for the flat, weak, everything-is-heavy version. Dizziness ran 8% versus 4%¹.

Roughly one in nine. Not rare, not imaginary, and not a sign the medication is wrong for you. I cannot overstate how much better I felt about my own sofa after reading a number.

The reasons, in the order they applied to me

I was eating far less than I understood. This is the big one. Semaglutide measurably reduces how much you eat and changes how you feel about food² — which is the entire point of taking it, and also a calorie deficit you did not consciously choose the size of. I was not tracking anything. I was simply not hungry, so I ate a yogurt at eleven and a bit of the kids' pasta at six and wondered why I could not stay awake.

I was barely drinking. Thirst went quiet along with appetite. Mild dehydration on its own will flatten an afternoon, and I had stopped noticing I was doing it.

Dose-increase weeks. Mine were reliably the worst. Same pattern as the mood dips, same timing, and both settled within about a week of the new dose.

Sleeping badly while feeling rough. Nausea at 2am is not restorative, and neither is lying there doing sums about whether this is working.

The one that is not universal. Low blood sugar is a real cause of this feeling, but on the label it is specifically tied to taking a GLP-1 alongside insulin or an insulin secretagogue — hypoglycemia was reported in 6% of trial participants with type 2 diabetes versus 2% on placebo¹. If that is not your medication list, it is probably not your explanation, and I spent a week worrying about the wrong thing.

What actually moved the needle for me

Eating on a clock instead of on hunger. This is the whole answer, really. Waiting to feel hungry meant not eating, and not eating meant the sofa. I put three eating times on my phone the way I have school pickup on my phone, and protein at each one, and the difference was not subtle.

Water where I could see it. A bottle on the counter I actually have to look at. Boring, free, worked.

Timing my shot so the worst day was not a working day. I moved mine so the flattest 48 hours landed over a weekend, which did not reduce the tiredness at all — it just put it somewhere it cost less.

Being patient with the escalation. I stopped treating the dose ladder as a race. If I felt wrecked, I sat on the dose that was working instead of climbing on schedule, and that was a conversation with my clinician rather than a decision I made alone.

It did not stay like this

Worth saying, because at week six I could not see past it. In the patient-reported outcomes pooled across the STEP 1–4 trials, semaglutide significantly improved physical functioning and weight-related quality of life compared with placebo³. Whatever the first two months feel like, the direction of travel over a year in the trials was toward being able to do more, not less.

Mine turned somewhere around month three. It was not a switch. It was noticing one evening that I had made it to the end of a film.

When I would stop managing it and call

Tiredness that comes with not being able to keep fluids down is a different problem. The label carries a specific warning about acute kidney injury from volume depletion — vomiting, diarrhea and not drinking enough — and tells clinicians to monitor kidney function in anyone reporting those¹. If you cannot keep fluids down, are passing very little urine, or feel faint on standing, that is a call to your clinician now, not a wait-and-see.

And if what you are describing is not exhaustion but flatness — nothing landing, nothing quite mattering — that is a different piece with a different answer.

Where this left me

I was tired for about ten weeks, and roughly four of the five reasons turned out to be things I could do something about. The one I could not do anything about was the medication working, which is an awkward thing to be annoyed by.

I would not have needed to feel like a failure about any of it if somebody had shown me the 11% in week one.